Two Sigma Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48M Buy
13,687,433
+9,289,444
+211% +$29.7M 0.04% 518
2025
Q4
$12M Buy
4,397,989
+1,657,135
+60% +$3.83M 0.02% 1006
2025
Q3
$5.95M Sell
2,740,854
-1,892,597
-41% -$4.47M 0.01% 1319
2025
Q2
$7.97M Buy
4,633,451
+4,236,457
+1,067% +$10.5M 0.01% 959
2025
Q1
$1.32M Buy
+396,994
New +$2.05M ﹤0.01% 2007
2024
Q4
Sell
-92,368
Closed -$867K 3344
2024
Q3
$867K Sell
92,368
-682,415
-88% -$6.47M ﹤0.01% 2209
2024
Q2
$6.21M Buy
+774,783
New +$8.3M 0.01% 911
2023
Q4
Sell
-227,000
Closed -$1.03M 3252
2023
Q3
$1.03M Sell
227,000
-1,304,053
-85% -$8.51M ﹤0.01% 1913
2023
Q2
$10.8M Sell
1,531,053
-1,026,134
-40% -$7.34M 0.03% 608
2023
Q1
$15.6M Buy
2,557,187
+1,663,254
+186% +$11.5M 0.05% 439
2022
Q4
$5.71M Sell
893,933
-517,225
-37% -$4.04M 0.02% 797
2022
Q3
$13.5M Buy
1,411,158
+877,558
+164% +$10.1M 0.05% 407
2022
Q2
$5.89M Buy
533,600
+408,700
+327% +$5.36M 0.02% 697
2022
Q1
$2.08M Sell
124,900
-256,981
-67% -$3.97M 0.01% 1337
2021
Q4
$7.29M Buy
381,881
+122,951
+47% +$2.71M 0.02% 972
2021
Q3
$6.38M Buy
+258,930
New +$6.1M 0.02% 1048
2021
Q2
Sell
-170,300
Closed -$5.39M 4373
2021
Q1
$5.39M Sell
170,300
-136,862
-45% -$5.67M 0.02% 994
2020
Q4
$14.3M Buy
307,162
+296,426
+2,761% +$11.8M 0.05% 475
2020
Q3
$353K Sell
10,736
-77,873
-88% -$2.39M ﹤0.01% 2483
2020
Q2
$2.43M Buy
+88,609
New +$2.91M 0.01% 998
2020
Q1
Sell
-189,327
Closed -$5.24M 3521
2019
Q4
$5.24M Sell
189,327
-312,443
-62% -$7.11M 0.02% 922
2019
Q3
$9.13M Buy
+501,770
New +$11.1M 0.04% 583
2019
Q2
Sell
-149,841
Closed -$1.43M 3561
2019
Q1
$1.43M Sell
149,841
-201,691
-57% -$1.96M 0.01% 1611
2018
Q4
$3.11M Buy
+351,532
New +$3.39M 0.01% 1024
2018
Q3
Sell
-263,475
Closed -$3.37M 3457
2018
Q2
$3.37M Buy
263,475
+249,075
+1,730% +$3.64M 0.01% 1267
2018
Q1
$243K Sell
14,400
-13,894
-49% -$210K ﹤0.01% 2882
2017
Q4
$226K Buy
+28,294
New +$227K ﹤0.01% 2868

Other funds holding IOVA